The Platelet Rich Plasma Market is being driven by Increasing incidence of musculoskeletal disorders
The Platelet Rich Plasma Market is expected to grow at a CAGR of 15.3% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 522.8 million. The global platelet rich plasma (PRP) market is experiencing robust growth, marked by the expansion of product offerings. On October 21, 2024, PRP Labs, a prominent distributor of EmCyte products in the US, announced the introduction of several new items to their portfolio. This expansion includes the latest Plasma Protein Concentrator and Adipose Concentrate Kits, specifically the EmCyte FC60 (60ml Plasma Protein Concentrating Kit), the FC120 (120ml Plasma Protein Concentration Kit), and the PK50 Progenikine Adipose Concentrate Kit. These new kits cater to the evolving needs of healthcare professionals in PRP procedures, offering dependable and superior-quality solutions for both medical and aesthetic regenerative therapies. This strategic expansion underscores PRP Labs' commitment to innovation and staying at the forefront of the PRP market.
Get more information on Platelet Rich Plasma Market by requesting a sample report
Which Factors Are Causing a Surge in Market Growth?
The market is segmented based on Product (Pure PRP, L-PRP, Others) End-user (Hospitals, Specialty clinics, Others) Geography (North America, Europe, Asia, Rest of World (ROW)).
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Key Features in Platelet Rich Plasma Market Research Report
Find out which segment is leading the market by accessing the free PDF report
Platelet-rich plasma (PRP), an autologous substance derived from a patient's own plasma, is gaining popularity in various medical applications. PRP is used in the treatment of sports injuries, orthopedic disorders, and musculoskeletal conditions. In cosmetic surgery, it is utilized for skin rejuvenation through procedures like micro-needling, collagen production, and vampire facials. PRP also plays a role in hair transplants, dental uses, and post-surgical healing. Its investigational uses include bone formation and tissue repair. PRP's low-risk procedure status makes it an attractive option for hair loss treatment and orthopedic treatment. Revenue streams for PRP include tendon injuries, muscle injuries, joint injuries, cosmetic PRP, and orthopedic surgery. The centrifugation process isolates platelets from the plasma, which contributes to its effectiveness in these applications.
The Platelet Rich Plasma (PRP) market encompasses businesses involved in the research and development (R&D) or production of PRP-related products for various applications, including sports injuries, cosmetic surgery, patient treatment activities, orthopedic disorders, musculoskeletal conditions, regenerative medicines, skin rejuvenation, micro-needling, and collagen production, collectively known as the aesthetics and regenerative medicine sectors. According to Technavio's market research, the global pharmaceuticals market, which includes the aforementioned sectors, is projected to experience significant growth due to several factors. One such factor is the increasing global population aging, with the proportion of individuals aged 60 and above predicted to rise significantly. By 2050, approximately one-quarter of the US population and Europe's population ratio is projected to reach this age group. This demographic shift will lead to a surge in demand for healthcare solutions, including those related to PRP therapy.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
